Opportunity ID: 355311

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-HL-25-007
Funding Opportunity Title: Phased Multi-Site Clinical Trial: Testing Prevention of Cardiovascular Disease in Young Adults With High Lifetime Risk Using Surrogate Outcomes – Data Coordinating Center (Collaborative U24 Trial Required)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.837 — Cardiovascular Diseases Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jul 10, 2024
Last Updated Date: Jul 10, 2024
Original Closing Date for Applications: Oct 28, 2024
Current Closing Date for Applications: Oct 28, 2024
Archive Date: Dec 03, 2024
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: County governments
Small businesses
For profit organizations other than small businesses
State governments
Public and State controlled institutions of higher education
Independent school districts
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Special district governments
Native American tribal organizations (other than Federally recognized tribal governments)
Private institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.

Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Additional Information

Agency Name: National Institutes of Health
Description: This NOFO will support applications to develop and implement a Data Coordinating Center (DCC) for a multi-site clinical trial among young adults without clinical atherosclerotic cardiovascular disease (ASCVD). It will utilize a milestone-driven cooperative agreement mechanism of award and runs in parallel with a companion NOFO that encourages applications for a collaborating Clinical Coordinating Center (RFA-HL-25-010). The objective of the DCC application is to present a comprehensive plan to provide overall project coordination, administration, data management, and biostatistical support for the clinical trial proposed in the collaborating CCC application. The application should also describe its approaches to collaborate with the CCC (RFA-HL-25-010) on implementation of the clinical trial community engagement and diversity plans, as well as reducing health inequities. Clinical trials using innovative designs such as platform trials, adaptive, and Bayesian designs are welcomed.
Applications for both a DCC and a Clinical Coordinating Center (CCC) must be submitted on the same application due date for consideration by NHLBI. Applicants are strongly encouraged to contact the appropriate Scientific/Research contact prior to submitting an application. Applicants are strongly encouraged to contact the appropriate Scientific/Research contact prior to submitting an application. This Notice of Funding Opportunity (NOFO) requires a Plan for Enhancing Diverse Perspectives (PEDP).
Link to Additional Information: https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-25-007.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH Grants Information
grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Version History

Version Modification Description Updated Date

Folder 355311 Full Announcement-RFA-HL-25-007 -> RFA-HL-25-007-Full-Announcement.pdf

Packages

Agency Contact Information: NIH Grants Information
grantsinfo@nih.gov
Email: grantsinfo@nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-H Use for due dates on or after January 25, 2023 PKG00287298 Sep 11, 2024 Oct 28, 2024 View

Package 1

Mandatory forms

355311 RR_SF424_5_0-5.0.pdf

355311 PHS398_CoverPageSupplement_5_0-5.0.pdf

355311 RR_OtherProjectInfo_1_4-1.4.pdf

355311 PerformanceSite_4_0-4.0.pdf

355311 RR_KeyPersonExpanded_4_0-4.0.pdf

355311 RR_Budget10_3_0-3.0.pdf

355311 PHS398_ResearchPlan_5_0-5.0.pdf

355311 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

355311 RR_SubawardBudget10_30_3_0-3.0.pdf

355311 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-13T03:25:19-05:00

Share This Post, Choose Your Platform!

About the Author: